These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9148400)

  • 21. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Can the prognosis of multiple sclerosis be predicted?].
    Moreau T; Confavreux C
    Pathol Biol (Paris); 2000 Mar; 48(2):132-8. PubMed ID: 10815289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
    Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
    Tintoré M; Rovira A; Río J; Tur C; Pelayo R; Nos C; Téllez N; Perkal H; Comabella M; Sastre-Garriga J; Montalban X
    Neurology; 2008 Mar; 70(13 Pt 2):1079-83. PubMed ID: 17881717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis: clinical presentation, diagnosis and treatment.
    Brod SA; Lindsey JW; Wolinsky JS
    Am Fam Physician; 1996 Sep; 54(4):1301-6, 1309-11. PubMed ID: 8816574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study.
    Kappos L; Clanet M; Sandberg-Wollheim M; Radue EW; Hartung HP; Hohlfeld R; Xu J; Bennett D; Sandrock A; Goelz S;
    Neurology; 2005 Jul; 65(1):40-7. PubMed ID: 16009883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
    Gladstone DE; Zamkoff KW; Krupp L; Peyster R; Sibony P; Christodoulou C; Locher E; Coyle PK
    Arch Neurol; 2006 Oct; 63(10):1388-93. PubMed ID: 16908728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Calabrese M; Filippi M; Rovaris M; Bernardi V; Atzori M; Mattisi I; Favaretto A; Grossi P; Barachino L; Rinaldi L; Romualdi C; Perini P; Gallo P
    Mult Scler; 2009 Jan; 15(1):36-41. PubMed ID: 18755823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple sclerosis].
    Nyland H; Myhr KM
    Tidsskr Nor Laegeforen; 1995 Jun; 115(17):2072-7. PubMed ID: 7544032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiple sclerosis. Clinical topodiagnosis in comparison with cerebral MRI findings].
    Baum K; Junge M; Felix R
    Nervenarzt; 1994 Aug; 65(8):542-8. PubMed ID: 7969651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple sclerosis: can therapy delay ongoing disability?].
    Havla J; Pellkofer HL; Hohlfeld R; Kümpfel T
    MMW Fortschr Med; 2011 Apr; 153(14):63-6. PubMed ID: 21966873
    [No Abstract]   [Full Text] [Related]  

  • 35. [Various forms in the course of multiple sclerosis].
    Poser S
    Psychiatr Neurol Med Psychol (Leipz); 1982 Dec; 34(12):705-11. PubMed ID: 7167597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Forms of disease progression and prognostic factors in multiple sclerosis].
    Meyer-Rienecker HJ; Hitzschke B; Buddenhagen F; Lakner K
    Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):588-97. PubMed ID: 3237865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis: early prognostic guidelines.
    Kraft GH; Freal JE; Coryell JK; Hanan CL; Chitnis N
    Arch Phys Med Rehabil; 1981 Feb; 62(2):54-8. PubMed ID: 7235886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis and factors that predict outcome in multiple sclerosis].
    Matsui M
    Nihon Rinsho; 2003 Aug; 61(8):1396-401. PubMed ID: 12962029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating the tools for an individualized prognosis in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2013 Aug; 331(1-2):10-3. PubMed ID: 23692966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.
    Brex PA; Ciccarelli O; O'Riordan JI; Sailer M; Thompson AJ; Miller DH
    N Engl J Med; 2002 Jan; 346(3):158-64. PubMed ID: 11796849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.